Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (550)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2025
3013
8.890
Why?
Hematopoietic Stem Cell Transplantation
28
2024
600
3.420
Why?
Pyrazines
20
2023
187
2.530
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1020
2.400
Why?
Boronic Acids
19
2014
180
2.350
Why?
Thalidomide
28
2023
376
2.330
Why?
Transplantation, Autologous
30
2024
479
1.870
Why?
Antineoplastic Agents
30
2020
1216
1.850
Why?
Transplantation Conditioning
9
2019
93
1.390
Why?
Drug Resistance, Neoplasm
17
2020
336
1.360
Why?
Paraproteinemias
8
2018
72
1.220
Why?
Neoplastic Stem Cells
5
2020
88
1.140
Why?
Humans
158
2025
52441
1.140
Why?
Protease Inhibitors
6
2011
60
1.020
Why?
Venous Thrombosis
7
2009
89
0.990
Why?
Melphalan
16
2023
176
0.950
Why?
Stem Cell Transplantation
13
2023
188
0.950
Why?
Angiogenesis Inhibitors
9
2009
183
0.950
Why?
Plasma Cells
12
2025
233
0.940
Why?
Aged
59
2025
10242
0.920
Why?
Prognosis
34
2025
2100
0.910
Why?
Gene Expression Regulation, Neoplastic
13
2020
853
0.900
Why?
Hematopoietic Stem Cell Mobilization
5
2014
60
0.890
Why?
Middle Aged
61
2025
13133
0.860
Why?
Alkaline Phosphatase
5
2011
92
0.800
Why?
Busulfan
3
2019
18
0.800
Why?
Treatment Outcome
39
2022
5508
0.750
Why?
Dexamethasone
16
2024
434
0.710
Why?
Male
69
2025
26874
0.670
Why?
Female
65
2025
28277
0.630
Why?
Chromosome Aberrations
9
2008
295
0.630
Why?
Thromboembolism
3
2009
48
0.630
Why?
Neoplasm Proteins
6
2021
328
0.600
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.570
Why?
Gene Expression Profiling
19
2025
1099
0.560
Why?
Disease-Free Survival
14
2019
461
0.550
Why?
Bone Remodeling
2
2010
151
0.540
Why?
Immunoglobulin Light Chains
3
2016
90
0.540
Why?
Survival Rate
18
2019
944
0.530
Why?
Blood Transfusion
1
2018
126
0.530
Why?
Anticoagulants
5
2009
276
0.530
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
123
0.530
Why?
Immunologic Factors
5
2012
114
0.520
Why?
Cell Line, Tumor
18
2023
1429
0.500
Why?
Follow-Up Studies
21
2024
2294
0.490
Why?
Receptors, Retinoic Acid
2
2013
22
0.480
Why?
Adult
39
2025
14205
0.480
Why?
Antineoplastic Agents, Alkylating
7
2008
78
0.480
Why?
Proteasome Inhibitors
6
2018
101
0.480
Why?
IMP Dehydrogenase
2
2006
3
0.470
Why?
Clinical Trials as Topic
9
2022
461
0.470
Why?
Mycophenolic Acid
2
2006
19
0.470
Why?
Combined Modality Therapy
13
2008
641
0.460
Why?
Cell Proliferation
15
2020
1013
0.450
Why?
Disease Progression
13
2025
870
0.450
Why?
Recurrence
16
2018
680
0.450
Why?
Retrospective Studies
19
2025
6694
0.440
Why?
Antigens, Neoplasm
5
2007
145
0.440
Why?
Apoptosis
9
2019
1120
0.440
Why?
Antibodies, Monoclonal
3
2015
475
0.430
Why?
Up-Regulation
5
2020
462
0.430
Why?
Osteogenesis
3
2012
368
0.430
Why?
Animals
30
2024
13485
0.420
Why?
Venous Thromboembolism
3
2011
80
0.410
Why?
Survival Analysis
12
2021
656
0.410
Why?
Signal Transduction
12
2020
1724
0.410
Why?
Doxorubicin
8
2018
246
0.400
Why?
Bone Diseases
3
2012
91
0.400
Why?
Thrombosis
4
2012
250
0.390
Why?
Neoplasms, Second Primary
2
2024
75
0.390
Why?
T-Lymphocytes
10
2024
318
0.380
Why?
Central Nervous System Neoplasms
2
2004
69
0.370
Why?
Myeloablative Agonists
5
2014
32
0.370
Why?
Bone Marrow
7
2022
354
0.370
Why?
Oligopeptides
2
2013
94
0.360
Why?
Transplantation, Homologous
6
2004
151
0.360
Why?
Osteoblasts
4
2007
478
0.350
Why?
Hematopoietic Stem Cells
2
2010
180
0.350
Why?
Risk Factors
18
2018
3971
0.350
Why?
Meta-Analysis as Topic
2
2015
39
0.340
Why?
Salvage Therapy
9
2012
137
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.330
Why?
Mice
19
2024
5899
0.330
Why?
Tumor Microenvironment
3
2024
257
0.330
Why?
Bone Marrow Transplantation
5
2007
110
0.330
Why?
Enzyme Inhibitors
2
2019
378
0.330
Why?
Membrane Proteins
4
2017
344
0.320
Why?
Ultrasonography, Doppler
2
2007
42
0.320
Why?
Remission Induction
10
2008
218
0.310
Why?
Prospective Studies
9
2019
2433
0.310
Why?
Cell Cycle Proteins
2
2021
168
0.310
Why?
Neoplasm, Residual
4
2022
169
0.310
Why?
Myelodysplastic Syndromes
4
2007
86
0.300
Why?
B-Lymphocytes
4
2021
178
0.300
Why?
Waldenstrom Macroglobulinemia
3
2018
38
0.300
Why?
Aged, 80 and over
12
2025
3449
0.300
Why?
Lymphoma, B-Cell
3
2021
60
0.290
Why?
Immunosuppressive Agents
3
2005
248
0.290
Why?
Neovascularization, Pathologic
1
2009
158
0.290
Why?
Bone Neoplasms
1
2010
188
0.290
Why?
Killer Cells, Natural
4
2024
111
0.280
Why?
Dose-Response Relationship, Drug
6
2016
1365
0.270
Why?
Brain Diseases, Metabolic
1
2007
5
0.270
Why?
Chromosome Deletion
3
2008
138
0.270
Why?
Proteasome Endopeptidase Complex
4
2018
137
0.270
Why?
Hyperammonemia
1
2007
23
0.260
Why?
Amyloidosis
2
2007
85
0.260
Why?
Farnesyltranstransferase
1
2006
4
0.260
Why?
Thrombophilia
4
2009
18
0.260
Why?
Small Molecule Libraries
2
2019
66
0.260
Why?
Research Design
1
2009
368
0.260
Why?
Hemostasis
1
2007
54
0.260
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
58
0.260
Why?
Bone and Bones
1
2010
492
0.250
Why?
Flow Cytometry
6
2018
396
0.250
Why?
Sirolimus
1
2006
72
0.250
Why?
Cell Survival
8
2018
598
0.240
Why?
Immunotherapy, Adoptive
4
2024
156
0.240
Why?
Gastrointestinal Neoplasms
1
2006
41
0.240
Why?
Caspases
1
2006
101
0.240
Why?
In Situ Hybridization, Fluorescence
6
2016
262
0.240
Why?
Diploidy
2
2004
25
0.230
Why?
beta 2-Microglobulin
5
2008
39
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Religion
1
2005
61
0.230
Why?
Activated Protein C Resistance
4
2011
10
0.220
Why?
Case-Control Studies
10
2018
1202
0.220
Why?
Enoxaparin
1
2004
31
0.220
Why?
Aneuploidy
1
2004
19
0.220
Why?
Attitude to Health
1
2005
191
0.210
Why?
Ubiquitination
2
2021
57
0.210
Why?
Adaptation, Psychological
1
2005
227
0.210
Why?
Osteolysis
2
2022
74
0.210
Why?
Multivariate Analysis
5
2008
601
0.200
Why?
Cancer Vaccines
3
2010
78
0.200
Why?
Cisplatin
6
2009
282
0.200
Why?
Pyrimidines
3
2015
199
0.200
Why?
Cell Communication
2
2006
74
0.200
Why?
Randomized Controlled Trials as Topic
4
2012
625
0.200
Why?
Blood Coagulation
1
2003
64
0.200
Why?
Mice, Inbred NOD
6
2020
91
0.200
Why?
Critical Illness
1
2005
306
0.190
Why?
Antigens, CD34
1
2003
73
0.190
Why?
Cytogenetic Analysis
6
2007
79
0.190
Why?
Parathyroid Hormone
3
2010
143
0.190
Why?
Graft vs Host Disease
5
2010
91
0.190
Why?
Leukemia, Myeloid
1
2002
41
0.190
Why?
Cyclophosphamide
4
2003
176
0.190
Why?
Bone Resorption
2
2022
300
0.190
Why?
STAT3 Transcription Factor
4
2015
89
0.180
Why?
Kidney
1
2007
716
0.180
Why?
Chromosome Disorders
1
2002
32
0.180
Why?
Etoposide
5
2009
70
0.180
Why?
Time Factors
9
2016
2987
0.180
Why?
Hypothyroidism
1
2002
56
0.180
Why?
Logistic Models
5
2018
930
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.180
Why?
Chromosomes, Human, Pair 1
3
2006
95
0.170
Why?
Antibodies, Bispecific
1
2022
104
0.170
Why?
Neoplasm Recurrence, Local
4
2024
639
0.170
Why?
Cytotoxicity, Immunologic
3
2012
55
0.160
Why?
DNA-Binding Proteins
2
2020
423
0.160
Why?
Xenograft Model Antitumor Assays
5
2019
218
0.160
Why?
Neoplasms
2
2009
1314
0.160
Why?
Predictive Value of Tests
5
2009
938
0.160
Why?
Glucuronidase
2
2018
47
0.160
Why?
Hematologic Neoplasms
2
2016
101
0.150
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
125
0.150
Why?
Osteoclasts
4
2022
423
0.150
Why?
Cytokines
4
2007
622
0.150
Why?
Syndecan-1
3
2017
73
0.150
Why?
Kaplan-Meier Estimate
6
2015
485
0.150
Why?
Healthcare Disparities
1
2022
291
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.150
Why?
Drug Tolerance
1
2018
60
0.140
Why?
Solvents
1
2018
32
0.140
Why?
Dendritic Cells
3
2010
132
0.140
Why?
T-Lymphocytes, Cytotoxic
3
2010
64
0.140
Why?
Jehovah's Witnesses
1
2018
6
0.140
Why?
Pyridines
1
2019
137
0.140
Why?
Vincristine
3
2003
89
0.140
Why?
Cell Differentiation
4
2022
667
0.140
Why?
Platelet Count
3
2008
78
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Iron
2
2017
123
0.140
Why?
Risk Assessment
5
2023
1349
0.140
Why?
Occupational Diseases
1
2018
85
0.130
Why?
Interleukin-6
2
2018
271
0.130
Why?
Arsenicals
2
2010
15
0.130
Why?
Pyruvate Kinase
1
2017
7
0.130
Why?
Mice, SCID
5
2018
178
0.130
Why?
Ascorbic Acid
1
2017
25
0.130
Why?
Oxides
2
2010
21
0.130
Why?
Drug Combinations
1
2017
136
0.130
Why?
Occupational Exposure
1
2018
111
0.130
Why?
RNA Splicing
1
2017
43
0.130
Why?
Anthropometry
1
2017
102
0.130
Why?
Transcription Factors
1
2020
570
0.130
Why?
Glycolysis
1
2017
70
0.130
Why?
Immunotherapy
4
2006
251
0.130
Why?
Factor V
3
2011
10
0.120
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.120
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.120
Why?
Tumor Cells, Cultured
6
2019
441
0.120
Why?
Fibrinolytic Agents
2
2007
131
0.120
Why?
Incidence
3
2009
1096
0.120
Why?
MicroRNAs
1
2020
392
0.120
Why?
Leukocytes, Mononuclear
2
2014
122
0.120
Why?
Reproductive History
1
2015
4
0.120
Why?
Oncolytic Virotherapy
1
2015
19
0.120
Why?
Hormone Replacement Therapy
1
2015
25
0.120
Why?
Cyclopentanes
1
2015
12
0.120
Why?
Cell Adhesion Molecules
1
2015
89
0.120
Why?
Ubiquitins
1
2015
19
0.120
Why?
Hemorrhage
2
2007
225
0.120
Why?
Cation Transport Proteins
1
2015
26
0.110
Why?
Receptors, Cell Surface
1
2015
111
0.110
Why?
NF-kappa B
3
2018
326
0.110
Why?
Aldehyde Dehydrogenase
1
2014
24
0.110
Why?
Postmenopause
1
2015
104
0.110
Why?
Drug Monitoring
1
2015
81
0.110
Why?
Intestines
1
2016
159
0.110
Why?
Protein-Tyrosine Kinases
1
2015
92
0.110
Why?
Leukapheresis
1
2014
18
0.110
Why?
Translocation, Genetic
3
2005
266
0.110
Why?
Transplantation Chimera
3
2003
16
0.110
Why?
Myeloma Proteins
2
2020
26
0.110
Why?
Antibodies
2
2024
144
0.110
Why?
Gene Deletion
3
2004
279
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
21
0.100
Why?
Polymorphism, Single Nucleotide
1
2016
506
0.100
Why?
Body Mass Index
1
2017
701
0.100
Why?
Veratrum Alkaloids
1
2013
5
0.100
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.100
Why?
Isoxazoles
1
2013
15
0.100
Why?
Biopsy
2
2006
594
0.100
Why?
Sulfones
1
2013
24
0.100
Why?
Hedgehog Proteins
1
2013
33
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Itraconazole
1
2013
37
0.100
Why?
Genetic Predisposition to Disease
1
2016
525
0.100
Why?
Metaphase
3
2008
47
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Carrier Proteins
2
2017
312
0.100
Why?
Renal Insufficiency
3
2009
109
0.100
Why?
B-Cell Maturation Antigen
2
2024
95
0.100
Why?
Wnt Proteins
1
2013
102
0.100
Why?
Risk
2
2011
315
0.100
Why?
Infusions, Intravenous
2
2003
212
0.100
Why?
Viremia
1
2012
23
0.090
Why?
Drug Delivery Systems
2
2005
148
0.090
Why?
Chromosomes, Human, Pair 11
2
2002
56
0.090
Why?
Radiopharmaceuticals
2
2021
198
0.090
Why?
Cytomegalovirus Infections
1
2012
38
0.090
Why?
Fluorodeoxyglucose F18
2
2021
181
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
48
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
49
0.090
Why?
Receptors, KIR
2
2008
11
0.090
Why?
Phosphorylation
2
2020
536
0.090
Why?
Medical Oncology
1
2012
97
0.090
Why?
Reoperation
2
2004
463
0.090
Why?
Alcohol Drinking
1
2013
235
0.090
Why?
Ligands
2
2009
205
0.090
Why?
Drug Evaluation, Preclinical
1
2012
141
0.090
Why?
Age Factors
3
2005
1120
0.090
Why?
Inflammation
1
2016
649
0.090
Why?
Smoking
1
2014
514
0.090
Why?
Tretinoin
2
2009
53
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
7
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
18
0.090
Why?
Recombinant Proteins
2
2010
490
0.080
Why?
Janus Kinase 1
1
2010
12
0.080
Why?
Macrophages
1
2013
357
0.080
Why?
Down-Regulation
2
2010
348
0.080
Why?
MAP Kinase Kinase 1
1
2010
22
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
56
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Authorship
1
2010
12
0.080
Why?
Neoplasm Staging
3
2015
768
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Bone Density Conservation Agents
1
2010
75
0.080
Why?
Conflict of Interest
1
2010
24
0.080
Why?
Drug Industry
1
2010
39
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Disclosure
1
2010
41
0.080
Why?
Mice, Transgenic
3
2021
566
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
71
0.080
Why?
Plasmacytoma
2
2011
44
0.080
Why?
Periodicals as Topic
1
2010
63
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
412
0.080
Why?
Cell Cycle
2
2010
236
0.080
Why?
Magnetic Resonance Imaging
3
2007
1507
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Cryoglobulinemia
1
2008
13
0.070
Why?
Blotting, Western
3
2015
587
0.070
Why?
Vascular Endothelial Growth Factor A
1
2009
186
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Prednisone
2
2009
100
0.070
Why?
Pulmonary Embolism
1
2009
81
0.070
Why?
Neutrophils
2
2014
148
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
580
0.070
Why?
Sulfonamides
1
2009
137
0.070
Why?
Polyethylene Glycols
1
2008
93
0.070
Why?
Immunophenotyping
2
2007
115
0.070
Why?
Adoptive Transfer
1
2007
30
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
21
0.070
Why?
Hemoglobins
1
2008
114
0.070
Why?
Histocompatibility Antigens Class I
1
2007
47
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
140
0.070
Why?
Phlebography
1
2007
54
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Ammonia
1
2007
87
0.070
Why?
Serum Albumin
2
2008
57
0.060
Why?
Chi-Square Distribution
1
2007
292
0.060
Why?
Cell Membrane
1
2007
238
0.060
Why?
Biomedical Research
1
2010
260
0.060
Why?
Brain
2
2007
1337
0.060
Why?
Drug Administration Schedule
2
2006
370
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Models, Genetic
1
2006
173
0.060
Why?
Guanosine
1
2006
7
0.060
Why?
Antibiotics, Antineoplastic
1
2006
83
0.060
Why?
Sex Factors
3
2016
735
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Renal Dialysis
1
2007
189
0.060
Why?
Survivors
1
2006
121
0.060
Why?
Guanosine Triphosphate
1
2004
15
0.060
Why?
Karyotyping
1
2005
77
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Gene Duplication
1
2005
16
0.060
Why?
Oncogene Proteins, Fusion
1
2005
61
0.060
Why?
Tissue Donors
2
2003
126
0.060
Why?
ROC Curve
1
2025
249
0.060
Why?
Kidney Transplantation
1
2007
199
0.050
Why?
Proteolysis
2
2015
100
0.050
Why?
Thrombophlebitis
1
2004
17
0.050
Why?
Genomic Instability
1
2005
87
0.050
Why?
Tomography, Emission-Computed
1
2004
53
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
RNA Interference
2
2015
183
0.050
Why?
Neoplastic Cells, Circulating
1
2004
34
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
333
0.050
Why?
Patient Selection
1
2005
269
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Confidence Intervals
1
2003
158
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Probability
1
2003
171
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Anxiety
1
2005
305
0.050
Why?
Cell Count
1
2003
143
0.050
Why?
Cyclosporine
1
2003
65
0.050
Why?
Transcriptome
1
2025
357
0.050
Why?
Drug Therapy, Combination
2
2017
404
0.050
Why?
Geography
1
2022
65
0.050
Why?
Thyroid Function Tests
1
2002
27
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
Tacrolimus
1
2003
61
0.050
Why?
Stromal Cells
1
2002
76
0.050
Why?
ABO Blood-Group System
1
2002
16
0.050
Why?
Administration, Oral
1
2003
455
0.050
Why?
Thyrotropin
1
2002
48
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
198
0.050
Why?
Fatal Outcome
1
2002
193
0.050
Why?
Genomics
1
2023
266
0.040
Why?
Chromosome Mapping
3
2006
149
0.040
Why?
Cell Division
1
2002
288
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Cells, Cultured
1
2005
1583
0.040
Why?
Graft Survival
1
2002
157
0.040
Why?
Acute Disease
1
2002
384
0.040
Why?
Tomography, X-Ray Computed
1
2006
1140
0.040
Why?
Cluster Analysis
3
2006
236
0.040
Why?
Young Adult
3
2015
4346
0.040
Why?
Pain
1
2003
373
0.040
Why?
Neoplasm Transplantation
1
2020
86
0.040
Why?
Depression
1
2005
603
0.040
Why?
Odds Ratio
2
2016
563
0.040
Why?
Staphylococcal Infections
1
2003
270
0.040
Why?
3' Untranslated Regions
1
2020
54
0.040
Why?
Postoperative Complications
1
2007
1065
0.040
Why?
Positron-Emission Tomography
1
2021
297
0.040
Why?
Antigens, CD
2
2015
213
0.040
Why?
Crystallography, X-Ray
1
2019
158
0.040
Why?
Mice, Nude
1
2019
230
0.040
Why?
Protein Conformation
1
2019
178
0.040
Why?
Bone Marrow Cells
2
2015
188
0.040
Why?
Coculture Techniques
2
2012
142
0.040
Why?
Mice, Inbred BALB C
1
2019
304
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
27
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Disease Management
1
2020
185
0.040
Why?
Drug Resistance
1
2018
69
0.040
Why?
Interferon-gamma
2
2010
169
0.040
Why?
Protein Stability
1
2018
45
0.040
Why?
Gene Knockdown Techniques
1
2018
110
0.040
Why?
Epidemiologic Methods
2
2008
47
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Cross-Sectional Studies
1
2022
1677
0.030
Why?
Microfilament Proteins
1
2017
44
0.030
Why?
HLA-A Antigens
2
2007
11
0.030
Why?
Calcium-Binding Proteins
1
2017
59
0.030
Why?
Transplantation, Heterologous
1
2017
78
0.030
Why?
Thyroid Hormones
1
2017
23
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Vaccination
2
2010
294
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
53
0.030
Why?
Genetic Loci
1
2016
46
0.030
Why?
Protein Binding
1
2018
673
0.030
Why?
Antibodies, Neoplasm
2
2006
27
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Mice, Knockout
1
2018
903
0.030
Why?
Microscopy, Electron, Transmission
1
2015
68
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Tumor Burden
1
2016
132
0.030
Why?
Genome-Wide Association Study
1
2016
184
0.030
Why?
ras Proteins
1
2015
62
0.030
Why?
Repressor Proteins
1
2016
150
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Disease Models, Animal
2
2013
1483
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Models, Biological
1
2018
735
0.030
Why?
RNA, Messenger
2
2010
1134
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Family
1
2016
170
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Adenine
1
2015
29
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Molecular Targeted Therapy
1
2016
135
0.030
Why?
Reactive Oxygen Species
1
2017
415
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
92
0.030
Why?
Drug Synergism
1
2014
147
0.030
Why?
Mitosis
1
2014
87
0.030
Why?
beta Catenin
1
2015
105
0.030
Why?
Piperidines
1
2015
99
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
135
0.030
Why?
Pyrazoles
1
2015
116
0.030
Why?
Cell Movement
1
2015
271
0.030
Why?
Proportional Hazards Models
2
2006
446
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Adolescent
2
2014
6713
0.020
Why?
Chromosomal Instability
1
2013
16
0.020
Why?
Membrane Glycoproteins
2
2006
239
0.020
Why?
Epitopes
1
2013
62
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
46
0.020
Why?
Immunoglobulin M
1
2012
59
0.020
Why?
Protein Kinase Inhibitors
1
2014
231
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.020
Why?
Cytomegalovirus
1
2012
32
0.020
Why?
Viral Load
1
2012
81
0.020
Why?
Interleukin-2
1
2012
69
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Peripheral Nervous System Diseases
1
2012
61
0.020
Why?
Immunoenzyme Techniques
1
2012
134
0.020
Why?
Arkansas
2
2008
2013
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Lymphocyte Activation
1
2012
161
0.020
Why?
Neoadjuvant Therapy
1
2012
124
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Chemotherapy, Adjuvant
1
2011
122
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
173
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
Interleukin-4
1
2010
41
0.020
Why?
Immunity, Cellular
1
2010
64
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Diagnosis, Differential
2
2004
1028
0.020
Why?
Mutation
1
2015
1331
0.020
Why?
Physician's Role
1
2010
50
0.020
Why?
RNA, Small Interfering
1
2010
217
0.020
Why?
Practice Guidelines as Topic
1
2012
498
0.020
Why?
Education, Medical, Continuing
1
2010
76
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Protein Isoforms
1
2009
127
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Safety
1
2009
78
0.020
Why?
Algorithms
1
2012
673
0.020
Why?
Vasculitis
1
2008
28
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
95
0.020
Why?
Twins
1
2007
32
0.020
Why?
Double-Blind Method
1
2009
726
0.020
Why?
Age Distribution
1
2007
176
0.020
Why?
C-Reactive Protein
1
2008
151
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Creatinine
1
2007
156
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
14
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Heterozygote
1
2006
89
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
86
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Cell Line
1
2008
1020
0.010
Why?
Transduction, Genetic
1
2005
44
0.010
Why?
Radiography
1
2007
469
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
202
0.010
Why?
Data Interpretation, Statistical
1
2006
166
0.010
Why?
Neoplasms, Experimental
1
2006
111
0.010
Why?
Sensitivity and Specificity
1
2007
871
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Monocytes
1
2005
124
0.010
Why?
Databases, Factual
1
2007
721
0.010
Why?
Clone Cells
1
2004
76
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
230
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
Fibroblasts
1
2005
357
0.010
Why?
History, 21st Century
1
2003
60
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Plasmapheresis
1
2003
12
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
5215
0.010
Why?
Perforin
1
2002
12
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
11
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Anemia
1
2003
75
0.010
Why?
Cohort Studies
1
2006
1576
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
1016
0.010
Why?
Quality Assurance, Health Care
1
2003
147
0.010
Why?
Erythrocyte Transfusion
1
2002
52
0.010
Why?
Cell Culture Techniques
1
2002
97
0.010
Why?
DNA, Neoplasm
1
2002
146
0.010
Why?
Graft Rejection
1
2002
166
0.010
Why?
Kidney Diseases
1
2003
230
0.010
Why?
Anti-Bacterial Agents
1
2003
816
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description